52426 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 13
00:18 UTC
|
REPX
Riley Exploration Permian
|
◎ Target | Gabe Daoud not yet tracked | Buy | $47.00→ $41.00-12.8% |
|
Aug 13
00:18 UTC
|
REFI
Chicago Atlantic Real Estate Finance
|
◎ Target | Chris Muller ★★★☆☆ #1886 | Market Outperform | $18.00→ $16.00-11.1% |
|
Aug 13
00:18 UTC
|
RDNW
RideNow Group
|
◎ Target | Michael Baker ★★★☆☆ #1580 | Neutral | $9.00→ $8.00-11.1% |
|
Aug 13
00:18 UTC
|
RDCM
Radcom
|
◎ Target | Ryan Koontz ★☆☆☆☆ #2974 | Buy | $18.00→ $14.00-22.2% |
|
Aug 13
00:18 UTC
|
RAPP
Rapport Therapeutics
|
◎ Target | Douglas Tsao ★★★☆☆ #1675 | Buy | $40.00→ $66.00+65.0% |
|
Aug 13
00:18 UTC
|
QUIK
QuickLogic
|
◎ Target | Neil Young not yet tracked | Buy | $22.00→ $20.00-9.1% |
|
Aug 13
00:18 UTC
|
QNT
Quantinuum
|
◎ Target | Mark Moerdler ★★★☆☆ #1364 | Outperform | $94.00→ $95.00+1.1% |
|
Aug 13
00:18 UTC
|
PSN
Persimmon
|
◎ Target | firm only | Buy | GBX 1,591→ GBX 1,590-0.1% |
|
Aug 13
00:18 UTC
|
PSI
Pason Systems
|
◎ Target | firm only | Outperform | C$16.00→ C$17.00+6.2% |
|
Aug 13
00:18 UTC
|
PRGS
Progress Software
|
◎ Target | Lucky Schreiner ★★★☆☆ #1373 | Buy | $45.00→ $55.00+22.2% |
|
Aug 13
00:18 UTC
|
PGNY
Progyny
|
◎ Target | Peter Warendorf ★★★★★ #315 | Equal Weight | $34.00→ $30.00-11.8% |
|
Aug 13
00:18 UTC
|
PET
Pet Valu
|
◎ Target | firm only | C$17.00→ C$19.00+11.8% | |
|
Aug 13
00:18 UTC
|
PET
Pet Valu
|
◎ Target | firm only | Sec→ r Perform | C$22.00→ C$23.00+4.5% |
|
Aug 13
00:18 UTC
|
PENN
PENN Entertainment
|
◎ Target | Stephen Grambling ★★★☆☆ #1288 | Equal Weight | $19.00→ $20.00+5.3% |
|
Aug 13
00:18 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Rustam Kanga ★★★★☆ #628 | Market Outperform | $320.00→ $415.00+29.7% |
|
Aug 13
00:18 UTC
|
ONON
ON
|
◎ Target | Jay Sole ★★★☆☆ #1894 | Buy | $83.00→ $73.00-12.0% |
|
Aug 13
00:18 UTC
|
ONON
ON
|
◎ Target | Cristina Fernandez ★★★☆☆ #1099 | Outperform | $51.00→ $43.00-15.7% |
|
Aug 13
00:18 UTC
|
ONON
ON
|
◎ Target | Jonathan Komp ★★★☆☆ #2259 | Outperform | $70.00→ $55.00-21.4% |
|
Aug 13
00:18 UTC
|
ONON
ON
|
◎ Target | Adrienne Yih ★★★☆☆ #1561 | Overweight | $46.00→ $42.00-8.7% |
|
Aug 13
00:18 UTC
|
ONON
ON
|
◎ Target | Jim Duffy not yet tracked | Buy | $60.00→ $41.00-31.7% |
|
Aug 13
00:18 UTC
|
ONIT
Onity Group
|
◎ Target | Bose George ★★☆☆☆ #2433 | Outperform | $58.00→ $55.00-5.2% |
|
Aug 13
00:18 UTC
|
OMDA
Omada Health
|
◎ Target | Vikram Kesavabhotla ★★☆☆☆ #2828 | Neutral | $15.00→ $25.00+66.7% |
|
Aug 13
00:18 UTC
|
OCDO
Ocado Group
|
◎ Target | firm only | Overweight | GBX 245→ GBX 290+18.4% |
|
Aug 13
00:18 UTC
|
NVRI
Enviri
|
◎ Target | Devin Dodge ★★☆☆☆ #2267 | Market Perform | $21.00→ $24.00+14.3% |
|
Aug 13
00:18 UTC
|
NTRA
Natera
|
◎ Target | Mason Carrico ★★★☆☆ #1311 | Overweight | $305.00→ $350.00+14.8% |
|
Aug 13
00:18 UTC
|
NTRA
Natera
|
◎ Target | Subbu Nambi ★★★★☆ #789 | Buy | $290.00→ $360.00+24.1% |
|
Aug 13
00:18 UTC
|
NTRA
Natera
|
◎ Target | David Westenberg ★★★☆☆ #1052 | Overweight | $249.00→ $363.50+46.0% |
|
Aug 13
00:18 UTC
|
NGNE
Neurogene
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $70.00→ $65.00-7.1% |
|
Aug 13
00:18 UTC
|
NGNE
Neurogene
|
◎ Target | Whitney Ijem ★★★☆☆ #2206 | Buy | $180.00→ $166.00-7.8% |
|
Aug 13
00:18 UTC
|
NGNE
Neurogene
|
◎ Target | Debjit Chattopadhyay ★☆☆☆☆ #3190 | Buy | $69.00→ $81.00+17.4% |
|
Aug 13
00:18 UTC
|
NFI
NFI Group
|
◎ Target | firm only | Sec→ r Outperform | C$27.00→ C$28.50+5.6% |
|
Aug 13
00:18 UTC
|
NEXN
Nexxen International
|
◎ Target | Tyler DiMatteo ★★★☆☆ #1192 | Buy | $10.00→ $13.00+30.0% |
|
Aug 13
00:18 UTC
|
NEXN
Nexxen International
|
◎ Target | Laura Martin ★★★☆☆ #2068 | Buy | $10.50→ $13.00+23.8% |
|
Aug 13
00:18 UTC
|
NEO
Neo Performance Materials
|
◎ Target | firm only | Buy | C$49.00→ C$55.00+12.2% |
|
Aug 13
00:18 UTC
|
NEM
Newmont
|
◎ Target | Tanya Jakusconek ★★☆☆☆ #2469 | Outperform | $147.00→ $149.00+1.4% |
|
Aug 13
00:18 UTC
|
NEM
Newmont
|
◎ Target | Tanya Jakusconek ★★☆☆☆ #2469 | Sec→ r Outperform | $147.00→ $149.00+1.4% |
|
Aug 13
00:18 UTC
|
NEM
Newmont
|
◎ Target | firm only | Buy | $127.00→ $133.00+4.7% |
|
Aug 13
00:18 UTC
|
NA
National Bank of Canada
|
◎ Target | firm only | Hold | C$202.00→ C$227.00+12.4% |
|
Aug 13
00:18 UTC
|
NA
National Bank of Canada
|
◎ Target | firm only | Market Perform | C$203.00→ C$226.50+11.6% |
|
Aug 13
00:18 UTC
|
MTZ
MasTec
|
◎ Target | Ati Modak not yet tracked | Buy | $508.00→ $409.00-19.5% |
|
Aug 13
00:18 UTC
|
MSFT
Microsoft
|
◎ Target | Michael Turrin ★★★☆☆ #1682 | Overweight | $650.00→ $700.00+7.7% |
|
Aug 13
00:18 UTC
|
MPLX
Mplx
|
◎ Target | Robert Kad ★★★☆☆ #1435 | Equal Weight | $60.00→ $66.00+10.0% |
|
Aug 13
00:18 UTC
|
MOBI
Mobia Medical
|
◎ Target | Robbie Marcus ★★★☆☆ #1132 | Overweight | $15.00→ $17.00+13.3% |
|
Aug 13
00:18 UTC
|
MNPR
Monopar Therapeutics
|
◎ Target | Jeet Mukherjee ★★★☆☆ #2058 | Buy | $117.00→ $133.00+13.7% |
|
Aug 13
00:18 UTC
|
MLCO
Melco Resorts & Entertainment
|
◎ Target | Joseph Stauff ★★☆☆☆ #2644 | Positive | $12.00→ $8.00-33.3% |
|
Aug 13
00:18 UTC
|
MIDD
Middleby
|
◎ Target | Tami Zakaria ★★★☆☆ #1354 | Neutral | $151.00→ $141.00-6.6% |
|
Aug 13
00:18 UTC
|
MFIC
MidCap Financial Investment
|
◎ Target | Kenneth S. Lee not yet tracked | Sec→ r Perform | $11.00→ $10.00-9.1% |
|
Aug 13
00:18 UTC
|
MDLN
Medline
|
◎ Target | Lisa Gill ★★★☆☆ #1908 | Overweight | $53.00→ $46.00-13.2% |
|
Aug 13
00:18 UTC
|
MDB
MongoDB
|
◎ Target | Ittai Kidron ★★★★★ #324 | Outperform | $410.00→ $475.00+15.9% |
|
Aug 13
00:18 UTC
|
MAU
Montage Gold
|
◎ Target | firm only | Buy | C$18.00→ C$21.00+16.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.